Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | AMGN | VRTX | REGN | GILD |
| Company | Inhibrx Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 13.23 | 311.03 | 472.14 | 1,027.47 | 66.62 |
| High | 13.87 | 313.41 | 476.57 | 1,040.05 | 66.93 |
| Low | 12.61 | 308.57 | 471.76 | 1,025.80 | 66.01 |
| Last | 12.89 | 310.88 | 474.57 | 1,034.23 | 66.69 |
| Change | -0.55 | +1.50 | +4.29 | +10.14 | +0.10 |
| % Change | -4.09% | +0.48% | +0.91% | +0.99% | +0.15% |
| Volume | 221,700 | 1,274,300 | 848,700 | 418,300 | 4,210,700 |
| 20-Day Average Volume | 294,970 | 2,367,100 | 1,245,350 | 479,745 | 9,101,460 |
| Previous Close | 13.44 | 309.38 | 470.28 | 1,024.09 | 66.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.03 | 308.01 | 475.19 | 1,037.74 | 66.78 |
| 20-Day Raw Stochastic | 5.86% | 50.55% | 48.89% | 47.23% | 42.18% |
| 20-Day Relative Strength | 34.78% | 55.72% | 60.13% | 56.49% | 49.00% |
| Weighted Alpha | N/A | +36.42 | +42.04 | +45.31 | -13.52 |
| Today's Opinion | N/A | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Previous Opinion | N/A | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Last Month's Opinion | N/A | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.32% since 06/27/24 | -0.90% since 06/27/24 | +0.44% since 06/27/24 | -1.58% since 06/27/24 | -3.11% since 06/27/24 |
| Low | 12.61 on 07/05/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 14.78 on 06/28/24 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,069.69 on 07/01/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -23.68% since 06/05/24 | +1.14% since 06/05/24 | -1.75% since 06/05/24 | +2.82% since 06/05/24 | +4.40% since 06/05/24 |
| Low | 12.61 on 07/05/24 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 992.22 on 06/10/24 | 62.69 on 06/18/24 |
| High | 17.39 on 06/10/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | N/A since 05/31/24 | +15.16% since 04/05/24 | +16.70% since 04/05/24 | +9.71% since 04/05/24 | -4.15% since 04/05/24 |
| Low | 12.61 on 07/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 18.95 on 06/05/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | N/A since 05/31/24 | +2.60% since 01/05/24 | +13.94% since 01/05/24 | +13.26% since 01/05/24 | -19.95% since 01/05/24 |
| Low | 12.61 on 07/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 18.95 on 06/05/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 194,557 | 165,962,256 | 121,357,168 | 112,840,368 | 82,961,352 |
| Shares Outstanding, K | 14,476 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 1,800,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -241,360,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -49,273,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | N/A | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.73 on 02/28/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 06/03/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.68 | 31.46 | 28.15 | 16.97 |